Access Anti-HAV IgM

Hepatitis A Virus IgM Antibody Assay · Beckman Coulter, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Access Anti-HAV IgM, covering 2024-12-04 to 2024-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Access Anti-HAV and Access Anti-HAV IgM Assays EU Clinical Trial Protocol (HAV-EU-11-23)